Connor, Clark & Lunn Investment Management (CC&L)’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-98,306
Closed -$9.68M 1816
2025
Q3
$9.68M Buy
+98,306
New +$9.74M 0.03% 421
2024
Q3
Sell
-54,474
Closed -$5.91M 1680
2024
Q2
$5.91M Sell
54,474
-11,397
-17% -$1.34M 0.02% 392
2024
Q1
$8.69M Sell
65,871
-1,780
-3% -$222K 0.04% 317
2023
Q4
$8.23M Buy
67,651
+48,112
+246% +$5.37M 0.04% 312
2023
Q3
$2.19M Buy
19,539
+560
+3% +$71.1K 0.01% 596
2023
Q2
$2.76M Buy
+18,979
New +$2.58M 0.01% 524
2022
Q4
Sell
-4,349
Closed -$455K 1454
2022
Q3
$455K Buy
+4,349
New +$477K ﹤0.01% 832
2022
Q2
Sell
-9,748
Closed -$1.25M 1220
2022
Q1
$1.25M Buy
+9,748
New +$1.18M 0.01% 618
2021
Q3
Sell
-11,052
Closed -$1.73M 1243
2021
Q2
$1.73M Buy
+11,052
New +$1.79M 0.01% 576
2020
Q4
Sell
-7,246
Closed -$958K 1063
2020
Q3
$958K Buy
+7,246
New +$947K 0.01% 632
2019
Q3
Sell
-8,369
Closed -$957K 1107
2019
Q2
$957K Buy
+8,369
New +$980K 0.01% 577
2015
Q2
Sell
-6,901
Closed -$787K 670
2015
Q1
$787K Sell
6,901
-721
-9% -$82.3K 0.01% 342
2014
Q4
$839K Buy
+7,622
New +$803K 0.01% 328

Other funds holding ZBH

Connor, Clark & Lunn Investment Management (CC&L)'s ZBH Position: Q4 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 98,306 shares — an estimated $9.68M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ZBH in Q4 2014 and held it in 13 quarters. The position peaked at $9.68M in Q3 2025. 947 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 98,306 Zimmer Biomet shares in Q4 2025, an estimated $9.68M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Zimmer Biomet in Q4 2014 and held it in 13 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Zimmer Biomet position peaked at $9.68M in Q3 2025.
  • 947 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2025, filed 10 Feb 2026.